Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence [Breast Cancer]
Conclusion
Both persistence and compliance are associated with DFS. Toxicity management and, for sequential treatments, patient and physician awareness, may improve adherence.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Chirgwin, Giobbie-Hurder, Coates, Price, Ejlertsen, Debled, Gelber, Goldhirsch, Smith, Rabaglio, Forbes, Neven, Lang, Colleoni, Thurlimann Tags: Hormonal Therapy Breast Cancer Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Hormonal Therapy | Hormones | Smokers | Study | Tamoxifen | Toxicology | Women